The company sources promising research from academic and biotech partners to establish new companies, provides expertise, infrastructure, and capital to help existing companies grow, and trains personnel to meet the standards of the pharmaceutical sector. With over 25 portfolio companies attracting $1.4 billion in investments and employing over 900 Canadians, adMare BioInnovations is committed to sustaining and growing the Canadian life sciences industry.